Analysis of composite time-to-event endpoints in cardiovascular outcome trials
Year: 2024
Type: article
Source: Clinical Trials
Institution: Merck & Co., Inc., Rahway, NJ, USA (United States)
Language: English
Subfield: Statistics and Probability
Field: Mathematics
Domain: Physical Sciences
Open Access status: closed
OpenAlex ID: W4401471694